Viewing Study NCT04462406


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-01-03 @ 5:53 PM
Study NCT ID: NCT04462406
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2020-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-02-09
Start Date Type: ACTUAL
Primary Completion Date: 2026-08-29
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-08-29
Completion Date Type: ESTIMATED
First Submit Date: 2020-06-26
First Submit QC Date: None
Study First Post Date: 2020-07-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-11
Last Update Post Date: 2025-11-13
Last Update Post Date Type: ESTIMATED